GB0402797D0 - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- GB0402797D0 GB0402797D0 GBGB0402797.5A GB0402797A GB0402797D0 GB 0402797 D0 GB0402797 D0 GB 0402797D0 GB 0402797 A GB0402797 A GB 0402797A GB 0402797 D0 GB0402797 D0 GB 0402797D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- organic compounds
- compounds
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0402797.5A GB0402797D0 (en) | 2004-02-09 | 2004-02-09 | Organic compounds |
TW094103838A TW200536533A (en) | 2004-02-09 | 2005-02-05 | Organic compounds |
PCT/EP2005/001241 WO2005074924A1 (en) | 2004-02-09 | 2005-02-08 | Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases |
RU2006132195/15A RU2006132195A (en) | 2004-02-09 | 2005-02-08 | The combination of beta-2 adrenoreceptor agonists, benzothiazole-2-ones and corticosteroids, intended for the treatment of respiratory diseases |
BRPI0507544-0A BRPI0507544A (en) | 2004-02-09 | 2005-02-08 | combination of benzothiazole-2-one beta-2 adrenoreceptor agonists and corticosteroids for the treatment of respiratory diseases |
CA002552938A CA2552938A1 (en) | 2004-02-09 | 2005-02-08 | Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases |
CNA2005800044314A CN1917875A (en) | 2004-02-09 | 2005-02-08 | Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases |
EP05707254A EP1715860A1 (en) | 2004-02-09 | 2005-02-08 | Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases |
AU2005210140A AU2005210140A1 (en) | 2004-02-09 | 2005-02-08 | Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases |
KR1020067016003A KR20060127974A (en) | 2004-02-09 | 2005-02-08 | Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases |
JP2006551821A JP2007522141A (en) | 2004-02-09 | 2005-02-08 | Combination of benzothiazol-2-one beta 2 adrenergic receptor agonist and corticosteroid for the treatment of respiratory diseases |
ARP050100452A AR047962A1 (en) | 2004-02-09 | 2005-02-09 | COMBINATION OF BETA-2 ADRENOCEPTOR AGONISTS AND CORTICOSTEROIDS FOR THE TREATMENT OF RESPIRATORY DISEASES |
PE2005000154A PE20050692A1 (en) | 2004-02-09 | 2005-02-09 | ORGANIC COMPOUNDS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0402797.5A GB0402797D0 (en) | 2004-02-09 | 2004-02-09 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0402797D0 true GB0402797D0 (en) | 2004-03-10 |
Family
ID=31985893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0402797.5A Ceased GB0402797D0 (en) | 2004-02-09 | 2004-02-09 | Organic compounds |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1715860A1 (en) |
JP (1) | JP2007522141A (en) |
KR (1) | KR20060127974A (en) |
CN (1) | CN1917875A (en) |
AR (1) | AR047962A1 (en) |
AU (1) | AU2005210140A1 (en) |
BR (1) | BRPI0507544A (en) |
CA (1) | CA2552938A1 (en) |
GB (1) | GB0402797D0 (en) |
PE (1) | PE20050692A1 (en) |
RU (1) | RU2006132195A (en) |
TW (1) | TW200536533A (en) |
WO (1) | WO2005074924A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200738659A (en) * | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200740781A (en) * | 2005-08-29 | 2007-11-01 | Astrazeneca Ab | Novel compounds |
AU2006315657B2 (en) * | 2005-11-10 | 2011-12-01 | Shell Internationale Research Maatschappij B.V. | Soft anticholinergic esters |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702456D0 (en) * | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
EP2011534A1 (en) * | 2007-07-03 | 2009-01-07 | CHIESI FARMACEUTICI S.p.A. | Metered dose inhaler actuator |
DK2225256T3 (en) | 2007-11-30 | 2013-03-11 | Pfizer Ltd | Novel glucocorticoid receptor agonists |
WO2009079078A1 (en) | 2007-12-14 | 2009-06-25 | Labogroup S.A.S. | Delivering aerosolizable food products |
MX2010007604A (en) | 2008-01-11 | 2010-08-02 | Novartis Ag | Pyrimidines as kinase inhibitors. |
KR20110017456A (en) | 2008-06-18 | 2011-02-21 | 아스트라제네카 아베 | Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
UY33597A (en) | 2010-09-09 | 2012-04-30 | Irm Llc | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE TRK |
GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
EP2678338B1 (en) | 2011-02-25 | 2015-09-09 | Novartis AG | Pyrazolo[1,5-a]pyridines as trk inhibitors |
JO3192B1 (en) * | 2011-09-06 | 2018-03-08 | Novartis Ag | Benzothiazolone compound |
HUE054804T2 (en) | 2016-06-02 | 2021-09-28 | Abbvie Inc | Glucocorticoid receptor agonist and immunoconjugates thereof |
DK3658192T3 (en) | 2017-12-01 | 2021-06-21 | Abbvie Inc | GLUCOCORTICOID RECEPTORAGONIST AND ITS IMMUNOCONJUGATES |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999009018A1 (en) * | 1997-08-14 | 1999-02-25 | Kirin Beer Kabushiki Kaisha | BENZOTHIAZOLONE DERIVATIVES HAVING SELECTIVE β2 RECEPTOR AGONIST ACTIVITY |
AR040962A1 (en) * | 2002-08-09 | 2005-04-27 | Novartis Ag | COMPOUNDS DERIVED FROM TIAZOL 1,3-2-ONA, PHARMACEUTICAL COMPOSITION AND COMPOSITE PREPARATION PROCESS |
-
2004
- 2004-02-09 GB GBGB0402797.5A patent/GB0402797D0/en not_active Ceased
-
2005
- 2005-02-05 TW TW094103838A patent/TW200536533A/en unknown
- 2005-02-08 JP JP2006551821A patent/JP2007522141A/en active Pending
- 2005-02-08 AU AU2005210140A patent/AU2005210140A1/en not_active Abandoned
- 2005-02-08 KR KR1020067016003A patent/KR20060127974A/en not_active Application Discontinuation
- 2005-02-08 WO PCT/EP2005/001241 patent/WO2005074924A1/en active Application Filing
- 2005-02-08 RU RU2006132195/15A patent/RU2006132195A/en not_active Application Discontinuation
- 2005-02-08 CN CNA2005800044314A patent/CN1917875A/en active Pending
- 2005-02-08 EP EP05707254A patent/EP1715860A1/en not_active Withdrawn
- 2005-02-08 CA CA002552938A patent/CA2552938A1/en not_active Abandoned
- 2005-02-08 BR BRPI0507544-0A patent/BRPI0507544A/en not_active IP Right Cessation
- 2005-02-09 AR ARP050100452A patent/AR047962A1/en not_active Application Discontinuation
- 2005-02-09 PE PE2005000154A patent/PE20050692A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0507544A (en) | 2007-06-12 |
KR20060127974A (en) | 2006-12-13 |
PE20050692A1 (en) | 2005-11-15 |
AU2005210140A1 (en) | 2005-08-18 |
CN1917875A (en) | 2007-02-21 |
TW200536533A (en) | 2005-11-16 |
EP1715860A1 (en) | 2006-11-02 |
WO2005074924A1 (en) | 2005-08-18 |
RU2006132195A (en) | 2008-03-20 |
AR047962A1 (en) | 2006-03-15 |
JP2007522141A (en) | 2007-08-09 |
CA2552938A1 (en) | 2005-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0410712D0 (en) | Organic compounds | |
GB0409921D0 (en) | Organic compounds | |
GB0403038D0 (en) | Organic compounds | |
GB0407723D0 (en) | Organic compounds | |
GB0401334D0 (en) | Organic compounds | |
GB0404434D0 (en) | Organic compounds | |
GB0405289D0 (en) | Organic compounds | |
GB0402797D0 (en) | Organic compounds | |
GB0408078D0 (en) | Organic compounds | |
GB0400781D0 (en) | Organic compounds | |
GB0403115D0 (en) | Organic compounds | |
GB0406515D0 (en) | Organic compounds | |
GB0403254D0 (en) | Organic compounds | |
GB0405723D0 (en) | Organic compounds | |
GB0409236D0 (en) | Organic compounds | |
GB0406240D0 (en) | Organic compounds | |
GB0407468D0 (en) | Organic compounds | |
GB0407607D0 (en) | Organic compounds | |
GB0405034D0 (en) | Organic compounds | |
GB0405898D0 (en) | Organic compounds | |
GB0405900D0 (en) | Organic compounds | |
GB0407466D0 (en) | Organic compounds | |
GB0404190D0 (en) | Organic compounds | |
GB0403964D0 (en) | Organic compounds | |
GB0410264D0 (en) | Organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |